Peripheral Vascular Devices | Market Insights | Europe (Part 2) | 2022
While the COVID-19 pandemic has had a negative impact on the European peripheral vascular device market in the short term, the dynamic nature of the PV market, the launch of novel premium-price products backed by clinical data, and improvement in reimbursement will lead to steady growth through the remainder of forecast period. However, revenue growth will be limited to some extent due to increasing price competition and ongoing cost constraints in the region.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Europe across an 11-year period.